Dietary fats and prevention of cardiovascular disease. Conclusion may have been underplayed.
Year: 2001
Type: letter
Abstract: Editor—The paper by Hooper et al may fulfil the Cochrane review criteria for a meta-analysis of clinical trials, but it does not provide a systematic review of the issues relating to dietary fat intake and the prevention of cardiovascular disease.1
It is important to consider the overall appropriateness of each trial before its inclusion in a meta-analysis. Several of the trials included are small or of short duration. It is difficult to imagine how the risk of coronary heart disease that has accrued over a prolonged period may be reversed by dietary modification in less than two years. The diet and infarction trial (fat modification arm) contributed the greatest number of cardiovascular end points, yet there are at least two reasons why this trial was unlikely to show a beneficial effect. Limited dietary instruction was given, so there was little change in cholesterol concentrations. Since modification of fat quality produces a predictable average change in cholesterol, there was clearly limited compliance with dietary advice. Furthermore, the study was too short (two years) to have the expected reduction in clinical events and mortality.
The Veterans' Administration study, which contributed the second largest number of deaths, fulfilled the criteria for a good randomised, controlled, double blind clinical trial. But the experimental diet entailed a ratio of polyunsaturated to saturated fatty acids of 1.5, far greater than would today be considered desirable. Such a diet would be expected to reduce cholesterol and coronary heart disease morbidity and mortality—as indeed it did, but perhaps not total mortality, as was also the case. Is it appropriate to compare such an intervention with that used in the Oslo study, in which saturated fats were replaced by whole grain cereals, vegetables, fruit, and some unsaturated fatty acids and in which study cardiovascular events and total mortality were reduced?
Meta-regression analyses were used to disentangle these issues, but one might question whether the statistical power was sufficient for this. One might also question why Hooper et al chose to examine total cardiovascular rather than coronary artery end points since there has never been any serious understanding that changing dietary fat does much to prevent strokes. The link is with coronary heart disease.
Finally, one might expect that in a systematic review the results of the trials would be interpreted in the context of the enormous body of descriptive epidemiology, which supports the link between dietary fat, cholesterol, and coronary heart disease. Although evidence based drug treatment now relies almost exclusively on clinical trials, when considering evidence based nutrition with links between nutrients and disease accumulating over a lifetime, it is imperative to consider epidemiological and experimental evidence in conjunction with trials.
It is nevertheless important to note the tentative conclusions offered by Hooper et al, when they say that there is a small but potentially important reduction in cardiovascular risk with reduction or modification of dietary fat intake, seen particularly in trials of longer duration. The conclusion seems to have been underplayed in the paragraph in This week in the BMJ that referred to this paper.
Source: PubMed
Authors: J Mann, M Skeaff, S Truswell
Language: English
Subfield: Nutrition and Dietetics
Field: Nursing
Domain: Health Sciences
Keywords: dietary fat, cardiovascular disease prevention, coronary artery disease, saturated fat, polyunsaturated fatty acids, cholesterol, meta-analysis critique, dietary adherence, stroke, all-cause mortality, evidence-based nutrition, trial design limitations, whole grain cereals, descriptive epidemiology
Open Access status: green
OpenAlex ID: W101970638
